Results 211 to 220 of about 2,243,245 (285)

Long Term Follow Up of Hereditary Thrombotic Thrombocytopenic Purpura on Plasma Therapy for 9 Years: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 7.6‐year‐old boy with hTTP had fever‐induced hemorrhagic rash, MAHA, cerebral infarction, and renal impairment. After plasma therapy, symptoms were partially relieved; 9‐year follow‐up showed regular plasma transfusion was needed, with CKD Stage 3.
Dai Xiaomei, Chen Ruyue, Wu Shuang, Tang Hanyun, Lin Qiang, Li Xiaozhong   +5 more
wiley   +1 more source

Plasma transfusion in neonatal sepsis. [PDF]

World J Pediatr
Ding FR, Li XY.
europepmc   +1 more source

Association of Iron Homeostasis With One‐Year All‐Cause Mortality Among Intensive Care Unit Patients with Atrial Fibrillation: A Retrospective Study

Clinical Cardiology, Volume 49, Issue 10, October 2026.
This retrospective study examined the prognostic role of iron markers (ferritin, serum iron, transferrin, TIBC) in intensive care unit patients with atrial fibrillation. Elevated ferritin was associated with increased mortality, whereas higher transferrin and TIBC predicted lower mortality, highlighting their potential for risk stratification. ABSTRACT
Mingze Wu, Juan Hua, Yao Zhou, Yu Zhang, Lin Zhang, Yu Wang, Qinmei Xiong   +6 more
wiley   +1 more source

Safety of red blood cell transfusion despite serologic incompatibility in autoimmune hemolytic anemia: A real-world multicenter study. [PDF]

Ann Hematol
Cammarata C, Raso S, Mattana M, Tomasello R, Camarda GM, D'Angelo S, Scirè E, Dilena MI, Fedele R, Siragusa S, Napolitano M.   +10 more
europepmc   +1 more source

Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc‐fusion protein SL‐172154 (SIRPα‐Fc‐CD40L) in patients with higher‐risk myelodysplastic syndrome or acute myeloid leukemia

Cancer, Volume 132, Issue 19, 1 October 2026.
Abstract Background This clinical trial sought to determine whether SL‐172154 could be combined safely and improve the efficacy of azacitidine (AZA) in patients with higher‐risk myelodysplastic syndrome (HR‐MDS) or acute myeloid leukemia (AML). Methods Dose escalation: doses of 1, 3, and 6 mg/kg SL‐172154 was evaluated as monotherapy or in combination ...
Naval G. Daver, Amer M. Zeidan, Anthony S. Stein, Joshua F. Zeidner, Keri Maher, Emily Curran, Dale Bixby, Wanxing Chai‐Ho, Maximilian Stahl, Karen W. L. Yee, Don Stevens, Sawa Ito, Jana Reynolds, Patrick Medd, Emma Searle, Andrew Sochacki, Mary Lynn Savoie, Steven Green, Kazunobu Kato, Robert Hernandez, Simon Metenou, Bo Ma, Lini Pandite, Taylor H. Schreiber, David A. Sallman   +24 more
wiley   +1 more source

Navigating the transition to digital transfusion safety in a resource-limited setting: a prospective implementation study and operational workflow analysis. [PDF]

BMJ Open Qual
Junta N, Boonyarat R, Butryojantho C, Puapairoj C, Jenwitheesuk K, Taebunpakul N, Chueyjundee C.   +6 more
europepmc   +1 more source

Lung‐Cardiovascular Interactions and Derangements in ARDS

Comprehensive Physiology, Volume 16, Issue 5, October 2026.
This review proposes an anatomical near‐ and far‐field framework for lung‐cardiovascular interactions in ARDS. Grounded in pathological and biological studies, the evidence spans pulmonary vascular, right ventricular, and systemic endothelial derangements and reviews available evidence for targeted therapies.
Pablo A. Sanchez, Connor O'Brien, Matthieu Legrand, Carolyn S. Calfee, Michael A. Matthay   +4 more
wiley   +1 more source

Vancomycin-induced immune hemolytic anemia: a case report and literature review. [PDF]

Front Immunol
Zhang R, Wang Y, Wang Z, Tao Y, Zheng S, Xu S, Wang L, Xiang D, Wu J.   +8 more
europepmc   +1 more source

[Indication for platelet transfusion and a new preventive measures for adverse reactions].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources